I noticed something interesting developing in the XRP market right now. Evernorth Holdings, a structure backed by figures connected to Ripple, has just filed with the SEC for a listing on Nasdaq under the ticker XPRN. It's a strategic move to create a public treasury vehicle dedicated to XRP.

The merger is going through Armada Acquisition Corp. II, sponsored by Arrington Capital. Once finalized, the combined entity should trade under XPRN, giving institutional and retail investors regulated exposure to XRP without directly holding the tokens. This is exactly the type of structure that big capital has been waiting for.

What struck me is the scale of the funding mobilized. Evernorth has raised over $1 billion from serious institutional investors. Ripple participated, of course, but also SBI Holdings, which committed $200 million alone, Pantera Capital, and other major players. This signals that institutions are taking XPRN seriously.

The company plans active management of the XRP portfolio, including lending, DeFi, and liquidity provision. The Form S-4 filing details a transparent structure with reporting standards aligned with public markets. The SPAC transaction is still under review by the SEC, but if it passes, XPRN would be among the first to offer this direct exposure via a listed share structure.

This timing is no coincidence. Earlier this week, U.S. regulators — SEC and CFTC — classified XRP as a digital commodity rather than a security. This marks the end of a long legal battle with Ripple that had blocked institutional engagement since 2020. The change in classification opens doors that many had been waiting for.

On the ground, more than 300 financial institutions across 55 countries already use the XRP Ledger for cross-border payments, with about 3 million transactions daily. Ripple’s stablecoin, launched at the end of 2024, has a market cap of around $1.5 billion.

Now, regarding price performance, it’s more mixed. XRP is currently trading around $1.40, up 0.72% over 24 hours, but remains below the key resistance of $1.50. The asset struggles to regain momentum and has been stuck below $1.80 since January 2026. Technical patterns show lower highs and lows since late 2025.

Analysts emphasize that breaking above $1.80 would be necessary to reverse the trend. Otherwise, a support zone between $1.20 and $1.30 could be tested. It’s interesting because fundamentals are improving — regulatory clarity, growing adoption, XPRN coming — but the price has not yet followed. This could be an opportunity to watch for those who believe in the long-term thesis.